Active Genetics & Molecular Biology Infection & Immunity

Discovering new pathways of lymphocyte specification and function

In plain English

AI plain-English summary

The immune system’s innate lymphoid cells (ILCs) are the body’s first responders, but scientists still don’t fully understand how they specialise into different types that fight infections or repair tissues. This project aims to map the molecular instructions—the environmental signals, surface receptors, and gene-regulating proteins—that turn a generic ILC into a specific subtype with a precise job. When these instructions go wrong, the result is chronic inflammation or autoimmune disease. By decoding the normal pathways of ILC specification, researchers hope to identify new targets for drugs that could dial down unwanted immune reactions without shutting down the entire system. The team will use genetically engineered “polychromILC” mice that make different ILC types glow in distinct colours, combined with CRISPR screens to find new regulators. They will also build a new generation of mouse strains that use Boolean logic—AND, OR, NOT—to control gene edits with surgical precision, avoiding off-target effects. This is fundamental science. It will not produce a treatment tomorrow. But understanding how ILCs are born and deployed is a prerequisite for designing therapies that nudge the immune system back toward balance—a goal that matters for millions of people with asthma, allergies, or inflammatory bowel disease.

View original technical description
The co-ordinated development and differentiation of lymphocytes is critical to producing the bespoke immune responses required to combat specific pathogens, but also to maintaining tissue homeostasis and repair. However, dysregulated immune reactions underlie undesirable chronic inflammation and autoimmunity. Our discovery of type-2 innate lymphoid cells (ILC2) and the description of other ILC subsets has highlighted additional, previously unappreciated, complexity in the processes of lymphocyte specialisation. Our challenge is to unravel the microenvironmental cues, critical cell-surface receptors, and key transcription factor interactions that lead to lymphocyte specification, tissue-specific roles and cellular interactions. We will employ a unique repertoire of lymphocyte transcription factor reporter “polychromILC” mice in combination with CRISPR-mediated screens to identify new regulators of lymphocyte development, differentiation and function. To facilitate the investigation of these new pathways in specific lymphocyte subsets in vivo we will produce a new generation of mouse strains designed to limit off-target events by employing multiple positive and negative determinants, comparable to Boolean operators (AND, OR, NOT or AND NOT). Finally, using a combination of genetic screens and in toto adaptive light-sheet microscopy we aim to define molecules and cells that delineate the migration and development of ILC in the context of the stromal environment.

View the original record at the funder ↗

Researchers

Andrew McKenzie (EPMC Awardee)

Related Research

Grants with similar aims, by meaning.

Innate lymphoid cells in immunity and disease.
The role of innate lymphoid cells in regulating intestinal inflammation
Initial characterisation of innate lymphoid cells after inducible deletion of RORα
Understanding the regulation of IL-17 producing lymphocytes by the cytokine TGF (beta).
The RNA-Binding Protein ZFP36L1 regulates the terminal differentiation of B lymphocytes

Original classification

Investigator Award in Science

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.